No Data
No Data
Alcon Canada Strengthens Its Commitment to Astigmatic Patients With TOTAL30 for Astigmatism Expanded Parameters
Baird Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $108
Stifel Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $100
A Quick Look at Today's Ratings for Alcon(ALC.US), With a Forecast Between $91.6 to $107
Baird Maintains Outperform on Alcon, Raises Price Target to $108
Analysts Conflicted on These Healthcare Names: Agilon Health (AGL), AN2 Therapeutics, Inc. (ANTX) and Alcon (ALC)
loading...